Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Odintsov

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
The American Journal of Surgical Pathology|June 12, 2026
Clinicopathologic Study of 39 Mismatch Repair-deficient Sarcomas Demonstrates Recurrent Histologic Patterns and Supports Universal Screening of Pleomorphic Rhabdomyosarcoma, Uterine Leiomyosarcoma, and Undifferentiated and Unclassified SarcomasIgor Odintsov, Jonathan A Nowak, Esther Baranov, et al.
The American Journal of Surgical Pathology|March 13, 2025
Malignant Giant Cell Tumor of Bone: A Clinicopathologic Series of 28 Cases Highlighting Genetic Differences Compared With Conventional, Atypical, and Metastasizing Conventional TumorsDavid J Papke, S Krisztian Kovacs, Igor Odintsov, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 9, 2026
Spatial transcriptomics reveals coordinated endothelial and epithelial activator protein-1 activation in CLADYasufumi Goda, Tatsuhiko Naito, Mudassir M Banday, et al.
Molecular Cancer Research : MCR|February 12, 2022
MYC Promotes Tyrosine Kinase Inhibitor Resistance in ROS1-Fusion-Positive Lung CancerSudarshan R Iyer, Igor Odintsov, Adam J Schoenfeld, et al.
Nature Medicine|March 20, 2024
A visual-language foundation model for computational pathologyMing Y Lu, Bowen Chen, Drew F K Williamson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 11, 2021
Novel Preclinical Patient-Derived Lung Cancer Models Reveal Inhibition of HER3 and MTOR Signaling as Therapeutic Strategies for NRG1 Fusion-Positive CancersIgor Odintsov, Marissa S Mattar, Allan J W Lui, et al.
Communications Biology|December 17, 2020
NTRK kinase domain mutations in cancer variably impact sensitivity to type I and type II inhibitorsRomel Somwar, Nicolle E Hofmann, Bryan Smith, et al.
The American Journal of Surgical Pathology|March 26, 2026
FOS and FOSB Immunohistochemistry and Molecular Testing Reveal Novel Patterns in Proliferative Fasciitis and Myositis, FOSB Rearrangement in Proliferative Funiculitis, and FOSL1::RELA Fusion in Pediatric Proliferative FasciitisSanhong Yu, Fleur Cordier, Esther Baranov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2021
The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic <i>NRG1</i> FusionsIgor Odintsov, Allan J W Lui, Whitney J Sisso, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 28, 2023
Prevalence and Therapeutic Targeting of High-Level ERBB2 Amplification in NSCLCIgor Odintsov, Maisam Makarem, Mizuki Nishino, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
The American Journal of Surgical Pathology|June 12, 2026
Clinicopathologic Study of 39 Mismatch Repair-deficient Sarcomas Demonstrates Recurrent Histologic Patterns and Supports Universal Screening of Pleomorphic Rhabdomyosarcoma, Uterine Leiomyosarcoma, and Undifferentiated and Unclassified SarcomasIgor Odintsov, Jonathan A Nowak, Esther Baranov, et al.
The American Journal of Surgical Pathology|March 13, 2025
Malignant Giant Cell Tumor of Bone: A Clinicopathologic Series of 28 Cases Highlighting Genetic Differences Compared With Conventional, Atypical, and Metastasizing Conventional TumorsDavid J Papke, S Krisztian Kovacs, Igor Odintsov, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 9, 2026
Spatial transcriptomics reveals coordinated endothelial and epithelial activator protein-1 activation in CLADYasufumi Goda, Tatsuhiko Naito, Mudassir M Banday, et al.
Molecular Cancer Research : MCR|February 12, 2022
MYC Promotes Tyrosine Kinase Inhibitor Resistance in ROS1-Fusion-Positive Lung CancerSudarshan R Iyer, Igor Odintsov, Adam J Schoenfeld, et al.
Nature Medicine|March 20, 2024
A visual-language foundation model for computational pathologyMing Y Lu, Bowen Chen, Drew F K Williamson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 11, 2021
Novel Preclinical Patient-Derived Lung Cancer Models Reveal Inhibition of HER3 and MTOR Signaling as Therapeutic Strategies for NRG1 Fusion-Positive CancersIgor Odintsov, Marissa S Mattar, Allan J W Lui, et al.
Communications Biology|December 17, 2020
NTRK kinase domain mutations in cancer variably impact sensitivity to type I and type II inhibitorsRomel Somwar, Nicolle E Hofmann, Bryan Smith, et al.
The American Journal of Surgical Pathology|March 26, 2026
FOS and FOSB Immunohistochemistry and Molecular Testing Reveal Novel Patterns in Proliferative Fasciitis and Myositis, FOSB Rearrangement in Proliferative Funiculitis, and FOSL1::RELA Fusion in Pediatric Proliferative FasciitisSanhong Yu, Fleur Cordier, Esther Baranov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2021
The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic <i>NRG1</i> FusionsIgor Odintsov, Allan J W Lui, Whitney J Sisso, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 28, 2023
Prevalence and Therapeutic Targeting of High-Level ERBB2 Amplification in NSCLCIgor Odintsov, Maisam Makarem, Mizuki Nishino, et al.
Pageof 5